Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Cressman

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
BMJ Open|January 14, 2025
Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohortRohit Vijh, Zeina Waheed, Sandra Peterson, et al.
Healthcarepapers|March 14, 2024
Relational Work Is the Work: Virtual Healthcare Transformation for Rural, Remote and First Nations Communities in British ColumbiaJohn Mah, John Pawlovich, Terri Aldred, et al.
Pharmacoeconomics - Open|March 26, 2024
A Canadian Simulation Model for Major Depressive Disorder: Study ProtocolShahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
Tobacco Control|May 22, 2023
Fifty-year forecasts of daily smoking prevalence: can Australia reach 5% by 2030?Stephen Wade, Marianne F Weber, Peter Sarich, et al.
British Journal of Cancer|November 3, 2022
Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomesSilvia Behar Harpaz, Marianne F Weber, Stephen Wade, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 14, 2023
Cost-effectiveness of pharmacogenomic-guided treatment for major depressionShahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
Statistical Methods in Medical Research|February 12, 2025
Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviourStephen Wade, Peter Sarich, Pavla Vaneckova, et al.
BMJ Open|January 20, 2019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohortNiloofar Taghizadeh, Alain Tremblay, Sonya Cressman, et al.
Chemistry & Biology|March 31, 2005
Synthetic erythropoietic proteins: tuning biological performance by site-specific polymer attachmentShiah-Yun Chen, Sonya Cressman, Feng Mao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2023
Economic impact of using risk models for eligibility selection to the International lung screening TrialSonya Cressman, Marianne F Weber, Preston J Ngo, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
BMJ Open|January 14, 2025
Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohortRohit Vijh, Zeina Waheed, Sandra Peterson, et al.
Healthcarepapers|March 14, 2024
Relational Work Is the Work: Virtual Healthcare Transformation for Rural, Remote and First Nations Communities in British ColumbiaJohn Mah, John Pawlovich, Terri Aldred, et al.
Pharmacoeconomics - Open|March 26, 2024
A Canadian Simulation Model for Major Depressive Disorder: Study ProtocolShahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
Tobacco Control|May 22, 2023
Fifty-year forecasts of daily smoking prevalence: can Australia reach 5% by 2030?Stephen Wade, Marianne F Weber, Peter Sarich, et al.
British Journal of Cancer|November 3, 2022
Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomesSilvia Behar Harpaz, Marianne F Weber, Stephen Wade, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 14, 2023
Cost-effectiveness of pharmacogenomic-guided treatment for major depressionShahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
Statistical Methods in Medical Research|February 12, 2025
Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviourStephen Wade, Peter Sarich, Pavla Vaneckova, et al.
BMJ Open|January 20, 2019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohortNiloofar Taghizadeh, Alain Tremblay, Sonya Cressman, et al.
Chemistry & Biology|March 31, 2005
Synthetic erythropoietic proteins: tuning biological performance by site-specific polymer attachmentShiah-Yun Chen, Sonya Cressman, Feng Mao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2023
Economic impact of using risk models for eligibility selection to the International lung screening TrialSonya Cressman, Marianne F Weber, Preston J Ngo, et al.
Pageof 4